Stock detail
Bristol-Myers Squibb (BMY) stock price, chart, and key data
View Bristol-Myers Squibb stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Bristol-Myers Squibb
BMY · XNYS
$61.61
+0.21%
+$0.13
Overnight $61.81 (+0.32%)
Key metrics
52-week range
$30.75 - $31.00
Close price
$61.48
Market cap
$125.6B
P/E ratio
37.95
Beta
1.01
About the company
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$66.14
12
Hold
/ 22
Recent calls
10/26/2026
Piper Sandler
David Amsellem
Buy · Price target $78.00
10/25/2026
Bernstein
Courtney Breen
Hold · Price target $61.00
10/19/2026
Goldman Sachs
Asad Haider
Hold · Price target $63.00
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app